359 related articles for article (PubMed ID: 32301056)
1. Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials.
Kryst J; Kawalec P; Mitoraj AM; Pilc A; Lasoń W; Brzostek T
Pharmacol Rep; 2020 Jun; 72(3):543-562. PubMed ID: 32301056
[TBL] [Abstract][Full Text] [Related]
2. Oral Ketamine for Depression: A Systematic Review.
Rosenblat JD; Carvalho AF; Li M; Lee Y; Subramanieapillai M; McIntyre RS
J Clin Psychiatry; 2019 Apr; 80(3):. PubMed ID: 30995364
[TBL] [Abstract][Full Text] [Related]
3. Ketamine administration in depressive disorders: a systematic review and meta-analysis.
Fond G; Loundou A; Rabu C; Macgregor A; Lançon C; Brittner M; Micoulaud-Franchi JA; Richieri R; Courtet P; Abbar M; Roger M; Leboyer M; Boyer L
Psychopharmacology (Berl); 2014 Sep; 231(18):3663-76. PubMed ID: 25038867
[TBL] [Abstract][Full Text] [Related]
4. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
[TBL] [Abstract][Full Text] [Related]
5. Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories.
Kishimoto T; Chawla JM; Hagi K; Zarate CA; Kane JM; Bauer M; Correll CU
Psychol Med; 2016 May; 46(7):1459-72. PubMed ID: 26867988
[TBL] [Abstract][Full Text] [Related]
6. Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression.
Zheng W; Zhou YL; Liu WJ; Wang CY; Zhan YN; Li HQ; Chen LJ; Li MD; Ning YP
J Psychiatr Res; 2018 Nov; 106():61-68. PubMed ID: 30278319
[TBL] [Abstract][Full Text] [Related]
7. A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes.
McGirr A; Berlim MT; Bond DJ; Fleck MP; Yatham LN; Lam RW
Psychol Med; 2015 Mar; 45(4):693-704. PubMed ID: 25010396
[TBL] [Abstract][Full Text] [Related]
8. Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials.
Goss AJ; Kaser M; Costafreda SG; Sahakian BJ; Fu CH
J Clin Psychiatry; 2013 Nov; 74(11):1101-7. PubMed ID: 24330897
[TBL] [Abstract][Full Text] [Related]
9. A Systematic Review on the Efficacy of Intravenous Racemic Ketamine for Bipolar Depression.
Joseph B; Parsaik AK; Ahmed AT; Erwin PJ; Singh B
J Clin Psychopharmacol; 2021 Jan/Feb 01; 41(1):71-75. PubMed ID: 33347027
[TBL] [Abstract][Full Text] [Related]
10. An Update on the Efficacy and Tolerability of Oral Ketamine for Major Depression: A Systematic Review and Meta-Analysis.
Nuñez NA; Joseph B; Pahwa M; Seshadri A; Prokop LJ; Kung S; Schak KM; Vande Voort JL; Frye MA; Singh B
Psychopharmacol Bull; 2020 Sep; 50(4):137-163. PubMed ID: 33012876
[TBL] [Abstract][Full Text] [Related]
11. Demographic variables, design characteristics, and effect sizes of randomized, placebo-controlled, monotherapy trials of major depressive disorder and bipolar depression.
Papakostas GI; Martinson MA; Fava M; Iovieno N
J Clin Psychiatry; 2016 May; 77(5):e619-24. PubMed ID: 27249092
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression.
Romeo B; Choucha W; Fossati P; Rotge JY
Psychiatry Res; 2015 Dec; 230(2):682-8. PubMed ID: 26548981
[TBL] [Abstract][Full Text] [Related]
13. Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression.
Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Li M; Ning Y
J Psychopharmacol; 2018 Oct; 32(10):1118-1126. PubMed ID: 30260273
[TBL] [Abstract][Full Text] [Related]
14. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
[TBL] [Abstract][Full Text] [Related]
15. Ketamine as a novel treatment for major depressive disorder and bipolar depression: a systematic review and quantitative meta-analysis.
Lee EE; Della Selva MP; Liu A; Himelhoch S
Gen Hosp Psychiatry; 2015; 37(2):178-84. PubMed ID: 25698228
[TBL] [Abstract][Full Text] [Related]
16. Sleep improvement is associated with the antidepressant efficacy of repeated-dose ketamine and serum BDNF levels: a post-hoc analysis.
Wang M; Zhang B; Zhou Y; Wang C; Zheng W; Liu W; Zhan Y; Lan X; Ning Y
Pharmacol Rep; 2021 Apr; 73(2):594-603. PubMed ID: 33387333
[TBL] [Abstract][Full Text] [Related]
17. Maintaining Rapid Antidepressant Effects Following Ketamine Infusion: A Major Unmet Need.
Papakostas GI
J Clin Psychiatry; 2020 Feb; 81(2):. PubMed ID: 32023369
[TBL] [Abstract][Full Text] [Related]
18. Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression.
Park M; Newman LE; Gold PW; Luckenbaugh DA; Yuan P; Machado-Vieira R; Zarate CA
J Psychiatr Res; 2017 Jan; 84():113-118. PubMed ID: 27718369
[TBL] [Abstract][Full Text] [Related]
19. KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE.
Bobo WV; Vande Voort JL; Croarkin PE; Leung JG; Tye SJ; Frye MA
Depress Anxiety; 2016 Aug; 33(8):698-710. PubMed ID: 27062450
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of long-term antidepressant treatment for bipolar disorders - A meta-analysis of randomized controlled trials.
Liu B; Zhang Y; Fang H; Liu J; Liu T; Li L
J Affect Disord; 2017 Dec; 223():41-48. PubMed ID: 28715727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
